An emerging role of CD9 in stemness and chemoresistance

Oncotarget. 2019 Jun 18;10(40):4000-4001. doi: 10.18632/oncotarget.27021.

Authors

Mujib Ullah¹, Asma Akbar¹, Avnesh S Thakor¹

Affiliation

¹ Interventional Regenerative Medicine and Imaging Laboratory, Stanford University School of Medicine, Department of Radiology, Palo Alto, California 94304, USA.

No abstract available

Keywords: CD9; cancer; chemoresistance; stem cells.

Publication types

Editorial